Healthcare Center

Validated Method

Download
Immediate Center

Company Profile

Download
Diagnostic Center

Announcement for Prospective Subjects

Download


Our Services


Cardiology

Bioequivalence Study

With more than 100+ studies conducted, Biometrik Riset Indonesia has built a brand of excellence in conducting Bioequivalence (BE) studies to support generic drugs.

read more
Gastroenterology

Clinical Research

Clinical trials are research studies intended to answer scientific questions and find better ways to treat or prevent diseases

read more

Need Expert or Preliminary Consulting?

Reserve Now! Just Make An Appointment

make an appointment

Biometrik Riset Indonesia Commitment to Bioequivalence Study

Effi Setiawati - Operation Director

Bioequivalence study is very beneficial in the pharmaceutical industry and the wider community in general, therefore Biometrik Riset Indonesia is always committed to being a reliable and affordable laboratory with high validity of test results and quality according to national and international regulations.


More About Biometrik Riset Indonesia

The Reasons Why You Choose to Use Biometrik Services

We are a Contract Research Organization in Bioequivalence Studies and Clinical Trial.


  • Bioanalytical Lab Services At Industry Leading Turnaround
  • Tailor-Made, High-Value Bioanalysis Services For Biotech
  • Preclinical/Clinical Bioanalysis On Your Drugs
  • Bioanalytical Solutions For Small And Large Molecules
  • The validity of the results can be justified
  • Free Preliminary Consulting with our expert team
  • Effective project management
  • In-Depth understanding of Local Regulatory (BPOM and Ethics Committee)

Testimonials

What Our Client Say

Our Happy Customers

With adequate clinical and laboratory facilities, Bioequivalence testing is carried out in accordance with applicable guidelines with a relatively fast timeline. Breaking code product is done comprehensively and clearly. Bioequivalence test report provided on time.

Bintang Agustri GultomRegulatory Affairs Manager - PT Amarox Pharma Global

The process of implementing the Bioequivalence study in Biometrics runs according to a mutually agreed timeline. During the development and preparation process of the Bioequivalence study Product, Biometrics can be a good discussion partner in providing input regarding the critical parameters of the Test Product that can affect the success of the Bioequivalence Study.  

Harbani IndriartoRnD Manager - PT Promed Rahardjo

Publication

Recent Articles and News

Search Articles and News.

Welcoming 2026: Strengthening Our Commitment to Reliable and Compliant BA/BE Services

Writer and Editor : Canaya Vania Rehansha

Depok, January 2026 : PT Biometrik Riset Indonesia extends its warmest wishes for a Happy New Year 2026 to all partners, clients, and stakeholders. The beginning of a new year marks an important moment for reflection as well as renewed commitment to delivering high-quality bioavailability and bioequivalence (BA/BE) studies for the pharmaceutical industry.

Reflecting on the Previous Year

Throughout 2025, PT Biometrik Riset Indonesia continued to actively support pharmaceutical companies through the execution of various BA/BE studies. The trust placed in...

PT Biometrik Riset Indonesia Participates in HISFARIN West Java

WhatsApp Image 2025-12-31 at 13.58.03.jpeg

Writer and Editor : Padantya Narastiti Putri S

Bekasi, December 18th 2025, PT Biometrik Riset Indonesia participated in the HISFARIN (Himpunan Seminat Farmasi Indonesia) event held at Harris Convention Hall, Bekasi. The event brought together various stakeholders from the pharmaceutical industry, including RnD and QA Team.

During the event, PT Biometrik Riset Indonesia team actively engaged with visitors through direct discussions, exchanging insights on analytical testing requirements needs of the pharmaceutical industry, as well as sharing PT Biometrik Riset Indonesia’s experience in condu...

Biometrik Completed Successful Bioequivalence Studies for Ministry of Health Projects 2025

Writer: Devita Nurul Anggraeni Editor: Oktaviani Utami Dewi

Jakarta, December, 22 2025 - PT Biometrik Riset Indonesia has completed bioequivalence studies and reported the results for four molecules on behalf of twelve pharmaceutical industries participating in the Ministry of Health’s Facilitation Program for Local Change of Active Pharmaceutical Ingredient (API) sources. The completed molecules include Sitagliptin, Sitagliptin–Metformin, Rivaroxaban, and Imatinib, covering a total of twelve projects: seven Sitagliptin projects, one Sitagliptin–Metformin project, three Rivaroxaban projects, ...


Our Happy Customers